← Back to Insights
November 3, 2021
Authors
David Burda
Topics
Consumerism Economics Policy
Channels
Blogs

Et Tu, Cancer Hospitals? Why Most Cancer Hospitals Don’t Reveal Their Prices for Oncology Care

Oncology care is expensive. A report released in October 2020 by the Cancer Action Network said cancer patients’ total out-of-pocket costs for cancer treatments, including surgical procedures, radiation therapy and chemotherapy drugs, were $5.6 billion in 2018. That only will grow higher as total U.S. spending on cancer care reaches $246 billon by 2030, or 22 percent more than in 2020, the report said.

One way patients can manage the cost of their cancer care and make it more affordable is by comparing prices for care among different providers and choosing the provider that offers the best care for them at the lowest price. It’s called shopping. 

You’d think that if any kind of hospital would adhere to the new hospital price transparency rules and help patients access oncology care without going bankrupt, it would be cancer hospitals given the high clinical and financial stakes for patients. But, alas, cancer hospitals are just as bad as other types of hospitals in deliberately or inadvertently not following the rules and making it harder for patients to shop for care.

That’s the sad takeaway from a short, two-page research letter in JAMA Oncology. You can download the letter here

Like a lot of other health services researchers who are making a career off of hospital noncompliance with the price transparency rules (read “Hospital Spotting: How New Price Transparency Regs Spawned a New Cottage Industry on 4sighthealth.com), three researchers from Memorial Sloan Kettering, OncoSpark and Duke University wanted to know the level of compliance with the new rules by National Cancer Institute-designated cancer centers.

Of the 63 NCI-designated hospitals included in the study, only 13, or about 20 percent, were in total  compliance with the rules. That means they had their prices in a complete machine-readable file that prospective patients could view, download or export. Further:

  • 24, or 38 percent, had partial machine-readable files with incomplete data or incorrect formatting
  • 41, or 65 percent, had a consumer-facing price transparency tool
  • 44, or 70 percent, had a chargemaster list on their websites

Beyond the high noncompliance rate, the researchers discovered why price transparency could benefit  cancer patients in shopping for care. Some of the hospitals charged commercially insured patients up to eight times the maximum allowable Medicare charges for the same services. 

That finding prompted a sobering conclusion from the researchers: “Many NCI-CCs will likely continue to keep their pricing opaque given the potential reduction in reimbursement that may follow true transparency.” 

In-other-words, we won’t publicly disclose our prices and pay the fines for noncompliance because if we do, we’ll make less money from patients with great insurance who are seriously ill or dying. 

The research letter may be only two pages long, but it speaks volumes about why hospitals of all stripes flaunt the rules. Given that defiant, anti-consumer attitude, I think stronger, more punitive enforcement measures are called for. 

Thanks for reading.

About the Authors

David Burda

Dave is 4sight Health’s biggest news junkie, resident journalist and healthcare historian. He began covering healthcare in 1983 and hasn’t stopped since. Dave writes his own column, “Burda on Health,” for us, contributes weekly blog posts, and manages our weekly e-newsletter and weekly podcast, 4sight Friday and 4sight Roundup.

Dave believes that healthcare is a business like any other business, and customers—patients—are king. If you do what’s right for patients, good business results will follow.

Dave’s personal experiences with the healthcare system both as a patient and family caregiver have shaped his point of view. It’s also been shaped by covering the industry for 35 years as a reporter and editor. He worked at Modern Healthcare for 25 years, the last 11 as editor.

Prior to Modern Healthcare, he did stints at the American Medical Record Association (now AHIMA) and the American Hospital Association. After Modern Healthcare, he wrote a monthly column for Twin Cities Business explaining healthcare trends to a business audience, and he developed and executed content marketing plans for leading healthcare corporations as the editorial director for healthcare strategies at MSP Communications.

When he’s not reading and writing about healthcare, Dave spends his time riding the trails of DuPage County, IL, on his bike, tending his vegetable garden and daydreaming about being a lobster fisherman in Maine. He lives in Wheaton, IL, with his lovely wife of 35 years and his three children, none of whom want to be journalists or lobster fishermen.

Recent Posts

Default Image
Outcomes
4sight Friday | What Doctors Don’t Like | Healthcare Over the Rainbow | Consumers on Healthcare Costs and Affordability
Read 11/19/2021 Edition here. Curated by David Burda, 4sight Health’s news editor and columnist. Columns here. Find 4sight Health… Read More
By November 19, 2021
Consumerism
Podcast: 4sight Friday Roundup, What Consumers Are Telling Us About Healthcare Affordability, 11/19/21
What Consumers Are Telling Us About Healthcare Affordability Two new surveys took the pulse of consumers on healthcare… Read More
By November 19, 2021
Economics
Cain Brothers House Calls Podcast: Moving Healthcare Home and Beyond: A Conversation with Paul Kusserow, Chairman and CEO of Amedisys
Moving Healthcare Home and Beyond: A Conversation with Paul Kusserow, Chairman and CEO of Amedisys As part of… Read More
By and November 18, 2021